Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 5, 1999, Pages 659-665

  Bar, Jacob ^a   Chen, Rony ^b   Schoenfeld, Alexander ^b   Orvieto, Raoul ^b   Yahav, Jacob ^b   Ben Rafael, Zion ^b   Hod, Moshe ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Diabetic nephropathy; IDDM; Outcome; Pregnancy

Indexed keywords

CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAUTERINE GROWTH RETARDATION; KIDNEY FUNCTION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; TREATMENT OUTCOME;

EID: 0032827305     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.5.659     Document Type: Article

References (27)

1. Lindheimer MD, Katz AI. Gestation in women with kidney disease: prognosis and management. In: Lindheimer MD, Davison JM, eds. Baillière's Clinical Obstetrics and Gynecology. London: Baillière Tindall, 1994; 387-404.
2. Cunningham FG, Cox SM, Harstad TW, Mason RA, Prichard JA. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol 1990; 163: 453-459.
3. Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996; 335: 226-232.
4. van Dijk DJ, Axer-Siegel B, Erman A, Hod M. Diabetic vascular complications and pregnancy. Diabetes Rev 1995; 3: 632-642.
5. Jovanovic R, Jovanovic L. Obstetrics management when normoglycemia is maintained in diabetic pregnant women with vascular compromise. Am J Obstet Gynecol 1984; 149: 617-623.
6. Reece EA, Coustan ER, Hayslett JP. Diabetic nephropathy: pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 1988; 159: 56-66.
7. Kitzmiller JL, Brown ER, Phillipe M. Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol 1981; 141: 741-751.
8. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, Collaborative Study Group. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy and retinopathy in Jewish IDDM patients. N Engl J Med 1993; 329: 1456-1462.
9. Kasiske BL, Kalil RSN, Ma JA, Liao J, Keane WF. Effects of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-138.
10. Davison JM, Lindheimer MD. Renal disorders. In: Creasey R, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice, 2nd Ed. Philadelphia, PA: WB Saunders, 1988; 824-844.
11. Bar J, Hod M, Erman A, Friedman S, Gelerenter I, Kaplan B, Boner G, Ovadia J. Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. Am J Kidney Dis 1996; 28: 220-225.
12. Redman CWG, Jefferies M. Revised definition of pre-eclampsia. Lancet 1988; i: 809-812.
13. Reece EA, Winn HN, Hayslett JP, Couleham J, Wan M, Hobbins JC. Does pregnancy alter the rate of progression of diabetic nephropathy? Am J Perinatol 1990; 7: 193-198.
14. Pierce J. California diabetes and pregnancy program data system report, 1992. California Department of Health Services, Maternal and Child Health Branch, Contract 97644.
15. Combs CS, Kitzmiller JL. Diabetic nephropathy and pregnancy. Clin Obstet Gynecol 1991; 34: 505-515.
16. Biesenbach G, Stroger H, Zazgornik J. Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type I diabetic patients with impaired renal function. Nephrol Dialysis Transplant 1992; 7: 105-109.
17. Main EK, Main DM, Landon MB, Gabbe SG. Factors predicting perinatal outcome in pregnancies complicated by diabetic nephropathy (Class F). Sixth Annual Meeting, Society of Perinatal Obstetricians, San Antonio, Texas, February 1986.
18. Kitzmiller JL, Combs AC. Management and outcome of pregnancies complicated by diabetic nephropathy. In: Dormhart A, Hadden DR, eds. Diabetes and Pregnancy - An International Approach to Diagnosis and Management. New York: John Wiley & Sons, 1996.
19. Katz AI, Davison JM, Hayslett JP, Singson E, Lindheimer MD. Pregnancy in women with kidney disease. Kidney Int 1980; 18: 192-206.
20. Imbasciati E, Ponticelli C. Pregnancy and renal disease: predictors of maternal outcome (editorial review). Am J Nephrol 1991; 11: 353-362.
21. Abe S. Pregnancy in IgA nephropathy. Kidney Int 1991; 40: 1098-1102.
22. Hemmelder MH, de Zeeuw, D, Fidler V, de Jong PE. Proteinuria: a risk factor for pregnancy-related renal function decline in primary glomerular disease. Am J Kidney Dis 1995; 26: 187-192.
23. Barr M. Teratogen update: Angiotensin-converting enzyme inhibitors. Teratology 1994; 50: 399-409.
24. Shotan A, Widerhorn J, Hurst A, Elbayam U. Risk of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994; 96: 451-456.
25. Hod M, van Dijk DJ, Karp M, Weintraub N, Rabinerson D, Bar J, Peled Y, Erman A, Boner G, Ovadia J. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome - preliminary report. Nephrol Dialysis Transplant 1995; 10: 2328-2333.
26. Bar J, Hod M, Merlob P. Angiotensin-converting enzyme inhibitors use in the first trimester of pregnancy. Int J Risk Safety Med 1997; 9: 1-4.
27. Feldkamp M, Jones KL, Ornoy A, Pastuozak A, Rosenwasser S, Schick B, Bar J. ACE inhibitors use in the first trimester of pregnancy. MMWR 1997; 46: 240-242.